RYTM Rhythm Pharmaceuticals, Inc. - Common Stock
$117,52
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$74–$122
90% of range
Analystenbewertung
BUY
22 analysts
Kursziel
$142
+20% upside
P/E (TTM)
-37.8
ROE
-309.1%
Nettogewinnmarge
-103.6%
Über Rhythm Pharmaceuticals, Inc. - Common Stock Unternehmensübersicht von Wikipedia
RYTM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$117.52
Marktkapitalisierung
$7.90B
P/E (TTM)
-37.8
EPS (TTM)
$-3.11
Umsatz (TTM)
$190M
Dividendenrendite
—
ROE
-309.1%
Verschuldungsgrad
0.8
52W-Spanne
$75 – $122
RYTM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$190M
2016-12-31
→
2025-12-31
EPS
$-3.11
2019-12-31
→
2025-12-31
Freier Cashflow
$-117M
2017-12-31
→
2025-12-31
Margen
-103.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
RYTM
Peer-Median
P/E (TTM)
-37.8
16.0
P/S (TTM) (K/V (TTM))
41.6
47.5
P/B (K/B)
56.8
8.5
EV / EBITDA
-39.8
—
Price / FCF (Kurs / FCF)
-67.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
RYTM
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-101.2%
—
Net Profit Margin (Nettogewinnmarge)
-103.6%
-140.2%
ROA
-45.1%
-45.0%
ROE
-309.1%
-86.5%
ROIC
-77.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
RYTM
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.8
0.0
Current Ratio (Liquiditätsgrad)
4.4
5.8
Quick Ratio
3.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
RYTM
Peer-Median
Revenue YoY (Umsatz YoY)
45.8%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
100.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
RYTM
Peer-Median
RYTM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
22 Analysten
- Starker Kauf 8 36,4%
- Kauf 12 54,5%
- Halten 2 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
15 Analysten · 2026-08-18
Median
$145.00
Jetzt
$117.52
Tief
$105.00
Hoch
$160.00
Median-Ziel
$145.00
+23,4%
Mittelwert-Ziel
$141.53
+20,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.00%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.73 | $-0.84 | 0.11% |
| 31. März 2026 | $-0.83 | $-0.87 | 0.04% |
| 31. Dezember 2025 | $-0.73 | $-0.84 | 0.11% |
| 30. September 2025 | $-0.82 | $-0.74 | -0.08% |
| 30. Juni 2025 | $-0.75 | $-0.69 | -0.06% |
| 31. März 2025 | $-0.81 | $-0.72 | -0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | — |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | — |
| ORKA | $1.48B | -3.3 | — | — | -25.9% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $190M | $130M | $77M | $24M | $3M | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $19M | $13M | $9M | $2M | $599.0K | · | · | · | · | · | |
| R&D Expense | $167M | $238M | $135M | $109M | $104M | $90M | $109M | $50M | $23M | $20M | |
| SG&A Expense | $195M | $144M | $118M | $92M | $68M | $46M | $37M | $28M | $10M | $6M | |
| Operating Expenses | $382M | $396M | $262M | $203M | $173M | $137M | $146M | $78M | $32M | $26M | |
| Operating Income | $-192M | $-266M | $-184M | $-179M | $-170M | $-137M | $-146M | $-78M | $-32M | $-26M | |
| Interest Expense | · | · | $14M | $5M | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | $447.0K | $3M | $5M | $4M | $566.0K | $33.0K | |
| Other Non-op | $1M | $2M | $190.0K | $-790.0K | $100M | $3M | $5M | $4M | $-1M | $33.0K | |
| Pretax Income | $-196M | $-260M | $-184M | $-181M | $-70M | · | · | · | · | · | |
| Income Tax | $497.0K | $346.0K | $564.0K | · | · | · | · | · | · | · | |
| Net Income | $-197M | $-261M | $-185M | $-181M | $-70M | $-134M | $-141M | $-74M | $-34M | $-26M | |
| EPS (Basic) | $-3.11 | $-4.34 | $-3.20 | $-3.47 | $-1.40 | $-3.04 | $-3.86 | · | · | · | |
| EPS (Diluted) | $-3.11 | $-4.34 | $-3.20 | $-3.47 | $-1.40 | $-3.04 | $-3.86 | · | · | · | |
| Shares (Basic) | 64,984,361 | 60,995,204 | 57,673,128 | 52,120,701 | 49,600,294 | 44,127,220 | 36,422,450 | · | · | · | |
| Shares (Diluted) | 64,984,361 | 60,995,204 | 57,673,128 | 52,120,701 | 49,600,294 | 44,127,220 | 36,422,450 | · | · | · | |
| EBITDA | $-192M | $-265M | $-183M | $-178M | $-169M | $-136M | $-145M | $-78M | $-32M | · |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $89M | $60M | $128M | $59M | $101M | $62M | $50M | $34M | $7M | |
| Short-term Investments | $335M | $231M | $216M | $206M | $236M | $72M | $230M | · | $114M | $4M | |
| Receivables | $26M | $19M | $15M | $6M | $1M | · | · | · | · | · | |
| Inventory | $26M | $19M | $9M | $3M | $111.0K | · | · | · | · | · | |
| Prepaid Expense | $26M | $16M | $9M | $12M | $12M | $9M | $10M | $7M | $3M | $638.0K | |
| Other Current Assets | $10M | $9M | $7M | $7M | $4M | $3M | $4M | $1M | $1M | $216.0K | |
| Current Assets | $467M | $374M | $308M | $354M | $308M | $182M | $302M | $259M | $151M | $11M | |
| PP&E (Net) | $1M | $632.0K | $1M | $2M | $3M | $3M | $4M | $1M | $840.0K | $930.0K | |
| PP&E (Gross) | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $2M | $1M | $1M | |
| Accum. Depreciation | $5M | $5M | $4M | $3M | $2M | $1M | $752.0K | $809.0K | $367.0K | $144.0K | |
| Intangibles | $5M | $6M | $7M | $8M | $5M | · | · | · | · | · | |
| Other Non-current Assets | $3M | $7M | $15M | $17M | · | · | · | · | · | · | |
| Total Assets | $480M | $392M | $333M | $382M | $330M | $187M | $309M | $260M | $152M | $12M | |
| Accounts Payable | $14M | $12M | $5M | $5M | $6M | $5M | $10M | $8M | $2M | $2M | |
| Accrued Liabilities | $84M | $63M | $48M | $33M | $30M | $13M | $14M | $6M | $4M | $3M | |
| Current Liabilities | $106M | $116M | $55M | $40M | $43M | $18M | $24M | $14M | $7M | $5M | |
| Capital Leases | $3M | $4M | $490.0K | $1M | $2M | · | · | · | · | · | |
| Total Liabilities | $210M | $228M | $163M | $118M | $45M | $21M | $28M | $14M | $7M | $5M | |
| Long-term Debt | $108M | $110M | · | · | · | · | · | · | · | · | |
| Total Debt | $108M | $110M | · | · | · | · | · | · | · | · | |
| Common Stock | $67.0K | $61.0K | $59.0K | $56.0K | $50.0K | $44.0K | $44.0K | $34.0K | $27.0K | $10.0K | |
| Paid-in Capital | $1.49B | $1.18B | $1.06B | $974M | $813M | $626M | $606M | $431M | $255M | $44M | |
| Retained Earnings | $-1.35B | $-1.16B | $-895M | $-710M | $-529M | $-459M | $-325M | $-185M | $-110M | $-77M | |
| AOCI | $-796.0K | $-39.0K | $134.0K | $-92.0K | $-1.0K | $49.0K | · | · | · | · | |
| Stockholders' Equity | $139M | $22M | $170M | $264M | $284M | $167M | $281M | $246M | $145M | $-33M | |
| Liabilities + Equity | $480M | $392M | $333M | $382M | $330M | $187M | $309M | $260M | $152M | $12M | |
| Shares Outstanding | 67,205,321 | 62,390,654 | 59,426,559 | 56,612,429 | 50,283,574 | 44,235,903 | 43,996,753 | 34,410,725 | 27,284,140 | 10,196,292 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $500.0K | $700.0K | $900.0K | $896.0K | $816.0K | $690.0K | $834.0K | $442.0K | $223.0K | $144.0K | |
| Stock-based Comp | $67M | $40M | $33M | $20M | $21M | $17M | $12M | $6M | $2M | $1M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $855.0K | $774.0K | $342.0K | · | · | · | · | · | |
| Other Non-cash | $14M | $106M | $15M | $-13M | $-98M | $-6M | $5M | $5M | $2M | · | |
| Operating Cash Flow | $-116M | $-114M | $-136M | $-173M | $-146M | $-122M | $-123M | $-62M | $-29M | $-23M | |
| CapEx | $953.0K | $0 | $47.0K | $281.0K | $434.0K | $214.0K | $3M | $722.0K | $133.0K | $1M | |
| Investing Cash Flow | $-137M | $-48M | $-6M | $28M | $-62M | $159M | $-28M | $-87M | $-110M | $-5M | |
| Debt Issued | $0 | $0 | $24M | $72M | · | · | · | · | · | · | |
| Net Debt Issued | $-20M | $-13M | $17M | $72M | · | · | · | · | · | · | |
| Stock Issued | $34M | $39M | $49M | $131M | $162M | · | $161M | $163M | $126M | · | |
| Net Stock Activity | $34M | $39M | $49M | $131M | $162M | · | $161M | $163M | $126M | · | |
| Financing Cash Flow | $218M | $191M | $74M | $214M | $166M | $2M | $163M | $165M | $167M | · | |
| Net Change in Cash | $-35M | $29M | $-68M | $68M | $-42M | $39M | $13M | $15M | $28M | $-28M | |
| Free Cash Flow | $-117M | · | $-136M | $-174M | $-146M | $-122M | $-126M | $-63M | $-30M | · | |
| Levered FCF | · | · | $-150M | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -101.2% | -204.0% | -238.1% | -757.9% | -5391.9% | · | · | · | · | · | |
| Net Margin | -103.6% | -200.3% | -238.5% | -766.2% | -2207.1% | · | · | · | · | · | |
| Pretax Margin | -103.3% | -200.0% | -237.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -100.9% | -203.5% | -236.9% | -754.1% | -5366.0% | · | · | · | · | · | |
| ROA | -45.1% | -71.9% | -51.6% | -50.9% | -27.0% | -54.1% | -49.5% | -36.0% | -41.1% | · | |
| ROE | -309.1% | -1582.1% | -100.6% | -66.4% | -23.0% | -73.7% | -65.4% | -28.7% | -60.2% | · | |
| ROIC | -77.9% | -202.1% | -108.9% | · | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | 3.2 | 5.6 | 8.9 | 7.1 | 10.1 | 12.4 | 19.0 | 22.4 | · | |
| Quick Ratio | 3.9 | 2.9 | 5.3 | 8.5 | 6.8 | 9.6 | 2.6 | 3.6 | 22.0 | · | |
| Debt / Equity | 0.8 | 5.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.7 | 5.0 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | -13.3 | -34.4 | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.9 | 1.0 | 1.6 | 1.4 | 10.8 | · | · | · | · | · | |
| Receivables Turnover | 8.5 | 7.8 | 7.3 | 6.5 | 6.2 | · | · | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 45.8% | 68.1% | 227.6% | 649.5% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 100.2% | 245.5% | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $190M | $130M | $77M | $24M | $3M | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-197M | $-261M | $-185M | $-181M | $-70M | $-134M | $-141M | $-74M | $-34M | · | |
| Market Cap | $7.19B | $3.49B | $2.73B | $1.65B | $502M | $1.32B | $1.01B | $925M | $793M | · | |
| Enterprise Value | $6.91B | $3.28B | · | · | · | · | · | · | · | · | |
| P/E | -34.4 | -12.9 | -14.4 | -8.4 | -7.1 | -9.8 | -5.9 | · | · | · | |
| P/S | 37.9 | 26.8 | 35.3 | 69.7 | 159.1 | · | · | · | · | · | |
| P/B | 51.7 | 160.7 | 16.1 | 6.2 | 1.8 | 7.9 | 3.6 | 3.8 | 5.5 | · | |
| P / Tangible Book | 53.8 | 224.5 | 16.8 | 6.4 | 1.8 | 7.9 | · | · | · | · | |
| P / Cash Flow | -62.2 | -30.7 | -20.1 | -9.5 | -3.4 | -10.8 | -8.2 | -14.9 | -26.9 | · | |
| P / FCF | -61.7 | · | -20.1 | -9.5 | -3.4 | -10.8 | -8.0 | -14.7 | -26.8 | · | |
| EV / EBITDA | -36.1 | -12.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | -59.3 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 36.4 | 25.2 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2.9% | -7.8% | -7.0% | -11.9% | -14.0% | -10.2% | -16.8% | · | · | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $60M | $57M | $51M | $49M | $33M | $42M | $33M | $29M | $26M | $24M | $23M | $19M | $11M | $9M | $4M | |
| Cost of Revenue | $9M | $7M | $5M | $5M | $6M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $497.0K | |
| R&D Expense | $43M | $42M | $42M | $46M | $42M | $37M | $41M | $38M | $30M | $129M | $30M | $34M | $34M | $38M | $24M | $21M | |
| SG&A Expense | $67M | $64M | $57M | $52M | $46M | $39M | $38M | $35M | $36M | $34M | $32M | $30M | $30M | $25M | $26M | $22M | |
| Operating Expenses | $120M | $112M | $104M | $104M | $94M | $80M | $83M | $77M | $70M | $166M | $66M | $66M | $66M | $64M | $51M | $44M | |
| Operating Income | $-49M | $-52M | $-47M | $-53M | $-45M | $-47M | $-41M | $-44M | $-40M | $-140M | $-41M | $-44M | $-47M | $-53M | $-42M | $-39M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $3M | $3M | $3M | · | $2M | |
| Other Non-op | $1M | $-2M | $58.0K | $274.0K | $2M | $-644.0K | $325.0K | $1M | $302.0K | $524.0K | $393.0K | $-159.0K | $-17.0K | $-27.0K | $-54.0K | $-370.0K | |
| Pretax Income | $-49M | $-55M | $-48M | $-53M | $-46M | $-49M | $-43M | $-44M | $-32M | $-141M | $-41M | $-44M | $-47M | $-52M | $-42M | $-41M | |
| Income Tax | $444.0K | $545.0K | $-31.0K | $111.0K | $337.0K | $80.0K | $-89.0K | $-344.0K | $479.0K | $300.0K | $196.0K | $368.0K | $0 | $0 | · | · | |
| Net Income | $-49M | $-56M | $-48M | $-53M | $-47M | $-49M | $-43M | $-44M | $-32M | $-141M | $-42M | $-44M | $-47M | $-52M | $-42M | $-41M | |
| EPS (Basic) | $-0.73 | $-0.83 | $-0.73 | $-0.82 | $-0.75 | $-0.81 | $-0.71 | $-0.73 | $-0.55 | $-2.35 | $-0.70 | $-0.76 | $-0.82 | $-0.92 | $-0.74 | $-0.79 | |
| EPS (Diluted) | $-0.73 | $-0.83 | $-0.73 | $-0.82 | $-0.75 | $-0.81 | $-0.71 | $-0.73 | $-0.55 | $-2.35 | $-0.70 | $-0.76 | $-0.82 | $-0.92 | · | $-0.79 | |
| Shares (Basic) | 68,592,661 | 67,974,193 | -128,020,218 | 66,261,055 | 63,684,359 | 63,059,165 | -121,380,096 | 61,219,918 | 61,011,824 | 60,143,558 | -113,778,469 | 57,874,960 | 56,867,662 | 56,708,975 | -100,004,851 | 51,400,922 | |
| Shares (Diluted) | 68,592,661 | 67,974,193 | -128,020,218 | 66,261,055 | 63,684,359 | 63,059,165 | -121,380,096 | 61,219,918 | 61,011,824 | 60,143,558 | -113,778,469 | 57,874,960 | 56,867,662 | 56,708,975 | · | 51,400,922 | |
| EBITDA | $-49M | $-52M | · | $-53M | $-45M | $-47M | · | $-44M | · | $-140M | · | $-44M | $-47M | $-53M | · | $-39M |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $62M | $54M | $52M | $136M | $106M | $89M | $48M | $162M | $53M | · | $65M | $116M | $110M | · | $185M | |
| Short-term Investments | $265M | $278M | $335M | $364M | $155M | $208M | $231M | $251M | $157M | $148M | · | $235M | $138M | $185M | · | $163M | |
| Receivables | $40M | $34M | $26M | $33M | $26M | $18M | $19M | $19M | $18M | $15M | · | $15M | $14M | $8M | · | $3M | |
| Inventory | $31M | $29M | $26M | $22M | $19M | $19M | $19M | $14M | $12M | $9M | · | $8M | $6M | $5M | · | · | |
| Prepaid Expense | $25M | $27M | $26M | $24M | $25M | $18M | $16M | $9M | $9M | $11M | · | $8M | $10M | $10M | · | $11M | |
| Other Current Assets | · | · | $10M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $427M | $430M | $467M | $495M | $361M | $369M | $374M | $340M | $357M | $236M | · | $329M | $284M | $318M | · | $362M | |
| PP&E (Net) | $103.0K | $1M | $1M | $237.0K | $297.0K | $462.0K | $632.0K | $801.0K | $973.0K | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $5M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | · | $7M | $7M | $8M | · | $8M | |
| Other Non-current Assets | · | · | $3M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $437M | $442M | $480M | $507M | $373M | $387M | $392M | $364M | $382M | $259M | · | $354M | $310M | $346M | · | $390M | |
| Accounts Payable | $16M | $12M | $14M | $14M | $16M | $12M | $12M | $5M | $5M | $8M | · | $4M | $8M | $13M | · | $5M | |
| Accrued Liabilities | · | · | $84M | · | · | $59M | $63M | $55M | $48M | $45M | · | $44M | $36M | $31M | · | $26M | |
| Current Liabilities | $124M | $103M | $106M | $104M | $129M | $112M | $116M | $98M | $55M | $54M | · | $50M | $46M | $46M | · | $33M | |
| Capital Leases | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $284.0K | · | $692.0K | $888.0K | $1M | · | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $36M | $35M | · | · | · | · | · | · | |
| Total Liabilities | $220M | $205M | $210M | $211M | $239M | $224M | $228M | $211M | $202M | $197M | · | $157M | $128M | $126M | · | $108M | |
| Long-term Debt | $106M | $108M | $108M | $109M | $110M | $110M | $110M | · | · | · | · | · | · | · | · | $73M | |
| Total Debt | $106M | $108M | · | $109M | $110M | $110M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $69.0K | $69.0K | $67.0K | $67.0K | $64.0K | $62.0K | $61.0K | $61.0K | $60.0K | $60.0K | · | $59.0K | $57.0K | $56.0K | · | $56.0K | |
| Paid-in Capital | $1.56B | $1.53B | $1.49B | $1.45B | $1.24B | $1.22B | $1.18B | $1.12B | $1.11B | $1.10B | · | $1.05B | $991M | $982M | · | $949M | |
| Retained Earnings | $-1.46B | $-1.41B | $-1.35B | $-1.30B | $-1.25B | $-1.20B | $-1.16B | $-1.11B | $-1.07B | $-1.04B | · | $-853M | $-809M | $-762M | · | $-668M | |
| AOCI | $-912.0K | $444.0K | $-796.0K | $-926.0K | $-2M | $-51.0K | $-39.0K | $-604.0K | $-617.0K | $-181.0K | · | $-113.0K | $-14.0K | $-6.0K | · | $-339.0K | |
| Stockholders' Equity | $103M | $123M | $139M | $149M | $-12M | $19M | $22M | $11M | $39M | $62M | $170M | $197M | $182M | $220M | $264M | $281M | |
| Liabilities + Equity | $437M | $442M | $480M | $507M | $373M | $387M | $392M | $364M | $382M | $259M | · | $354M | $310M | $346M | · | $390M | |
| Shares Outstanding | 68,816,868 | 68,445,084 | 67,205,321 | 66,684,077 | 63,913,185 | 63,494,892 | 62,390,654 | 61,436,251 | 61,095,949 | 60,964,468 | · | 59,089,352 | 56,896,068 | 56,852,404 | · | 55,756,256 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $23M | $19M | $19M | $16M | $13M | $11M | $11M | $10M | $8M | $9M | $9M | $9M | $6M | $5M | $5M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | $214.0K | · | $214.0K | |
| Operating Cash Flow | $-9M | $-44M | $-25M | $-27M | $-23M | $-40M | $-19M | $-25M | $-29M | $-41M | $-29M | $-29M | $-41M | $-36M | $-34M | $-47M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $-1.0K | $1.0K | $0 | $47.0K | $-1.0K | $95.0K | |
| Investing Cash Flow | $14M | $57M | $30M | $-246M | $54M | $25M | $21M | $-91M | $-9M | $30M | $23M | $-95M | $48M | $18M | $-41M | $-40M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-3M | $38M | |
| Net Debt Issued | · | $-4M | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-1M | · | · | |
| Stock Issued | $0 | $0 | · | · | $0 | $34M | · | · | · | · | $0 | · | · | · | $14M | · | |
| Net Stock Activity | · | $0 | · | · | · | $34M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1M | $-5M | $-3M | $189M | $-889.0K | $32M | $38M | $2M | $146M | $4M | $2M | $73M | $-965.0K | $-133.0K | $17M | $159M | |
| Net Change in Cash | $3M | $8M | $2M | $-83M | $30M | $17M | $42M | $-114M | $108M | $-7M | $-5M | $-51M | $6M | $-18M | $-57M | $72M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -68.1% | -87.1% | · | -102.6% | -93.4% | -143.7% | · | -132.0% | · | -538.7% | · | -195.3% | -242.5% | -458.0% | · | · | |
| Net Margin | -69.2% | -92.6% | · | -103.1% | -96.1% | -151.3% | · | -131.2% | · | -544.4% | · | -196.2% | -243.0% | -455.0% | · | · | |
| Pretax Margin | -68.6% | -91.6% | · | -102.9% | -95.5% | -151.1% | · | -132.3% | · | -543.3% | · | -194.6% | · | · | · | · | |
| EBITDA Margin | -68.1% | -87.1% | · | -102.6% | -93.4% | -143.7% | · | -132.0% | · | -538.7% | · | -195.3% | -242.5% | -458.0% | · | · | |
| ROA | -12.2% | -13.4% | · | -12.2% | -12.4% | -15.3% | · | -12.2% | · | -46.8% | · | -11.9% | -15.9% | -16.6% | · | -11.0% | |
| ROE | -108.3% | -78.5% | · | -66.1% | -340.0% | -122.9% | · | -41.8% | · | -100.5% | · | -18.4% | -24.7% | -22.9% | · | -13.5% | |
| ROIC | -23.4% | -22.9% | · | -20.5% | -46.6% | -36.6% | · | -388.2% | · | -227.6% | · | -22.4% | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.2 | · | 4.7 | 2.8 | 3.3 | · | 3.5 | · | 4.4 | · | 6.6 | 6.2 | 6.9 | · | 10.9 | |
| Quick Ratio | 3.0 | 3.6 | · | 4.3 | 2.4 | 3.0 | · | 3.3 | · | 4.0 | · | 6.3 | 5.8 | 6.6 | · | 10.6 | |
| Debt / Equity | 1.0 | 0.9 | · | 0.7 | -9.2 | 5.8 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.9 | 0.8 | · | 0.7 | -8.9 | 5.7 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -29.4 | · | -14.0 | -14.1 | -17.2 | · | -18.3 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | 0.1 | · | 0.1 | 0.1 | 0.0 | · | · | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.4 | · | 0.4 | · | 0.6 | 0.7 | 0.5 | · | · | |
| Receivables Turnover | 2.1 | 2.3 | · | 2.0 | 2.2 | 2.0 | · | 2.0 | · | 2.3 | · | 2.5 | 2.5 | 2.6 | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $231M | $193M | · | $166M | $144M | $121M | · | $111M | $97M | $79M | · | $57M | $44M | $26M | · | $16M | |
| Net Income TTM | $-204M | $-205M | · | $-193M | $-172M | $-267M | · | $-261M | $-264M | $-284M | · | $-184M | $-185M | $-191M | · | $-174M | |
| Market Cap | $7.64B | $5.95B | · | $6.73B | $4.04B | $3.36B | · | $3.22B | · | $2.64B | · | $1.35B | $938M | $1.01B | · | $1.37B | |
| Enterprise Value | $7.42B | $5.72B | · | $6.43B | $3.86B | $3.16B | · | · | · | · | · | · | · | · | · | · | |
| P/E | -35.5 | -27.1 | · | -32.5 | -22.2 | -11.9 | · | -11.9 | -9.2 | -8.9 | · | -7.0 | -4.8 | -4.9 | · | -7.1 | |
| P/S | 33.1 | 30.9 | · | 40.6 | 28.1 | 27.8 | · | 29.0 | · | 33.4 | · | 23.6 | 21.3 | 38.5 | · | 86.0 | |
| P/B | 74.2 | 48.4 | · | 45.3 | -339.2 | 177.5 | · | 287.0 | · | 42.9 | · | 6.9 | 5.1 | 4.6 | · | 4.9 | |
| P / Tangible Book | 77.9 | 50.5 | · | 47.0 | · | 259.0 | · | 666.8 | 76.6 | 48.2 | · | 7.1 | 5.4 | 4.8 | · | 5.0 | |
| P / Cash Flow | · | -134.7 | · | · | · | -83.4 | · | · | · | -64.8 | · | · | · | -27.8 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -27.8 | · | · | |
| EV / EBITDA | -152.7 | -109.3 | · | -122.1 | -85.2 | -67.2 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 32.1 | 29.7 | · | 38.8 | 26.9 | 26.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2.8% | -3.7% | · | -3.1% | -4.5% | -8.4% | · | -8.4% | -10.9% | -11.2% | · | -14.3% | -20.7% | -20.5% | · | -14.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $190M | $130M | $77M | $24M | $3M |
| Betriebsgewinnmarge % | -101.2% | -204.0% | -238.1% | -757.9% | -5391.9% |
| Nettoergebnis | $-197M | $-261M | $-185M | $-181M | $-70M |
| Verwässerte EPS | $-3.11 | $-4.34 | $-3.20 | $-3.47 | $-1.40 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.8 | 5.1 | — | — | — |
| Liquiditätsgrad | 4.4 | 3.2 | 5.6 | 8.9 | 7.1 |
| Quick Ratio | 3.9 | 2.9 | 5.3 | 8.5 | 6.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-117M | — | $-136M | $-174M | $-146M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 320 Einreicher · $7.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 64 (+5 vs. Vorquartal) | 38 (-8 vs. Vorquartal) | 99 (-4 vs. Vorquartal) | 94 (+10 vs. Vorquartal) | +9.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $740.218.912 | 6.666.837 | 10,63% | Aktien |
| BAKER BROS. ADVISORS LP | $622.265.747 | 5.604.483 | 8,94% | Aktien |
| VANGUARD GROUP INC | $612.335.379 | 5.720.622 | 8,80% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $351.837.748 | 3.168.853 | 5,05% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $348.289.452 | 3.136.895 | 5,00% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $333.753.626 | 3.005.977 | 4,79% | Aktien |
| PERCEPTIVE ADVISORS LLC | $287.156.334 | 2.586.295 | 4,13% | Aktien |
| STATE STREET CORP | $285.728.722 | 2.573.529 | 4,10% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $245.220.303 | 2.208.595 | 3,52% | Aktien |
| Polar Capital Holdings Plc | $184.713.061 | 1.663.632 | 2,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $181.683.274 | 1.636.344 | 2,61% | Aktien |
| Capital Research Global Investors | $170.131.602 | 1.532.303 | 2,44% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $145.911.779 | 1.313.860 | 2,10% | Aktien |
| CITADEL ADVISORS LLC | $140.303.282 | 1.263.652 | 2,02% | Aktien |
| Checkpoint Capital L.P. | $131.681.580 | 1.186.000 | 1,89% | Aktien |
| Siren, L.L.C. | $126.160.613 | 1.136.275 | 1,81% | Aktien |
| Pictet Asset Management Holding SA | $106.252.095 | 957.785 | 1,53% | Aktien |
| MORGAN STANLEY | $94.763.217 | 853.492 | 1,36% | Aktien |
| FMR LLC | $89.815.609 | 808.931 | 1,29% | Aktien |
| Woodline Partners LP | $84.259.668 | 758.891 | 1,21% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $77.814.059 | 894.723 | 1,12% | Aktien |
| Clearbridge Investments, LLC | $77.329.368 | 696.473 | 1,11% | Aktien |
| Rock Springs Capital Management LP | $76.899.156 | 692.598 | 1,10% | Aktien |
| NORGES BANK | $76.149.259 | 685.844 | 1,09% | Aktien |
| Integral Health Asset Management, LLC | $61.066.500 | 550.000 | 0,88% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $49.488.625 | 445.723 | 0,71% | Aktien |
| Candriam S.C.A. | $48.032.508 | 433.025 | 0,69% | Aktien |
| Squarepoint Ops LLC | $46.956.919 | 422.921 | 0,67% | Aktien |
| Point72 Asset Management, L.P. | $45.989.736 | 414.210 | 0,66% | Aktien |
| Sofinnova Investments, Inc. | $45.303.238 | 408.027 | 0,65% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $44.078.910 | 397.000 | 0,63% | Aktien |
| BRAIDWELL LP | $42.316.642 | 381.128 | 0,61% | Aktien |
| LOOMIS SAYLES & CO L P | $40.081.941 | 361.001 | 0,58% | Aktien |
| Artisan Partners Limited Partnership | $39.395.220 | 354.816 | 0,57% | Aktien |
| AMERIPRISE FINANCIAL INC | $38.809.678 | 349.540 | 0,56% | Aktien |
| ORBIMED ADVISORS LLC | $35.851.587 | 322.900 | 0,52% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $35.165.311 | 316.719 | 0,51% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $35.155.873 | 316.634 | 0,51% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $34.581.515 | 311.461 | 0,50% | Aktien |
| Capital World Investors | $24.587.594 | 221.450 | 0,35% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $21.914.435 | 197.374 | 0,31% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $21.452.661 | 193.215 | 0,31% | Aktien |
| Assenagon Asset Management S.A. | $20.706.096 | 186.491 | 0,30% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $17.616.744 | 160.094 | 0,25% | Aktien |
| First Turn Management, LLC | $17.100.619 | 154.018 | 0,25% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $16.449.317 | 148.152 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $16.099.572 | 145.002 | 0,23% | Aktien |
| Nicholas Investment Partners, LP | $15.463.148 | 139.270 | 0,22% | Aktien |
| ADAR1 Capital Management, LLC | $15.117.623 | 136.158 | 0,22% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $15.085.313 | 135.867 | 0,22% | Aktien |
| Qube Research & Technologies Ltd | $14.923.542 | 134.410 | 0,21% | Aktien |
| NEXTBio Capital Management LP | $14.629.091 | 131.758 | 0,21% | Aktien |
| BlackRock, Inc. | $14.611.659 | 131.601 | 0,21% | Aktien |
| Driehaus Capital Management LLC | $14.354.514 | 129.285 | 0,21% | Aktien |
| SummitTX Capital, L.P. | $14.034.303 | 126.401 | 0,20% | Aktien |
| Logos Global Management LP | $13.878.750 | 125.000 | 0,20% | Aktien |
| Opaleye Management Inc. | $13.601.175 | 122.500 | 0,20% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $13.530.782 | 121.866 | 0,19% | Aktien |
| Longaeva Partners L.P. | $12.221.516 | 110.074 | 0,18% | Aktien |
| Swiss National Bank | $12.179.991 | 109.700 | 0,17% | Aktien |
| PFM Health Sciences, LP | $11.275.097 | 101.550 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.991.970 | 99.000 | 0,16% | Kaufoption |
| Aberdeen Group plc | $10.541.854 | 94.946 | 0,15% | Aktien |
| AXIOM INVESTORS LLC /DE | $9.646.286 | 86.880 | 0,14% | Aktien |
| First Light Asset Management, LLC | $9.522.488 | 85.765 | 0,14% | Aktien |
| ALGERT GLOBAL LLC | $9.263.344 | 83.431 | 0,13% | Aktien |
| Granahan Investment Management, LLC | $9.245.468 | 83.270 | 0,13% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $8.926.812 | 80.400 | 0,13% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $8.863.942 | 80.552 | 0,13% | Aktien |
| Atom Investors LP | $8.156.819 | 73.465 | 0,12% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8.153.155 | 73.432 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $8.142.147 | 73.333 | 0,12% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $7.610.884 | 68.548 | 0,11% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.581.239 | 68.281 | 0,11% | Aktien |
| PICTON MAHONEY ASSET MANAGEMENT | $7.314.658 | 65.880 | 0,11% | Aktien |
| Blue Owl Capital Holdings LP | $6.823.349 | 61.455 | 0,10% | Aktien |
| ExodusPoint Capital Management, LP | $6.789.151 | 61.147 | 0,10% | Aktien |
| PRUDENTIAL FINANCIAL INC | $6.444.736 | 58.045 | 0,09% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.347.585 | 57.170 | 0,09% | Aktien |
| Trexquant Investment LP | $6.245.215 | 56.248 | 0,09% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $6.210.463 | 55.935 | 0,09% | Aktien |
| CITIGROUP INC | $6.124.526 | 55.161 | 0,09% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.915.567 | 53.279 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $5.842.843 | 52.624 | 0,08% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5.723.148 | 65.806 | 0,08% | Aktien |
| Nan Fung Group Holdings Ltd | $5.453.794 | 49.120 | 0,08% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $5.384.622 | 48.497 | 0,08% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.362.749 | 48.300 | 0,08% | Verkaufsoption |
| CANADA PENSION PLAN INVESTMENT BOARD | $5.262.822 | 47.400 | 0,08% | Aktien |
| Hillsdale Investment Management Inc. | $4.885.320 | 44.000 | 0,07% | Aktien |
| Cinctive Capital Management LP | $4.745.311 | 42.739 | 0,07% | Aktien |
| Zweig-DiMenna Associates LLC | $4.674.363 | 42.100 | 0,07% | Aktien |
| TD Asset Management Inc | $4.305.521 | 38.778 | 0,06% | Aktien |
| EFG International AG | $3.726.164 | 33.563 | 0,05% | Aktien |
| FIRST TRUST ADVISORS LP | $3.606.476 | 32.482 | 0,05% | Aktien |
| Exome Asset Management LLC | $3.576.165 | 32.209 | 0,05% | Aktien |
| Rafferty Asset Management, LLC | $3.575.943 | 32.207 | 0,05% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.573.945 | 32.189 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $3.564.507 | 32.104 | 0,05% | Aktien |
| Schonfeld Strategic Advisors LLC | $3.176.234 | 28.607 | 0,05% | Aktien |
Unternehmensinsider 36 Insider · 12 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David P Meeker | President and CEO | 11. Februar 2026 A | 239.016 | 0 | 0 | $0 |
| Keith Michael Gottesdiener | CEO & President | 9. März 2020 M | 558.250 | 0 | 0 | $0 |
| Hunter C Smith | Chief Financial Officer | 18. Mai 2026 M | 119.611 | 0 | 23 | $-2.217.136 |
| Manher Joshi | Chief Medical Officer | 17. August 2026 A | — | 0 | 0 | $0 |
| Christopher Paul German | Corporate Controller & CAO | 15. Mai 2026 M | 0 | 0 | 2 | $-930.921 |
| Pamela J. Cramer | Chief Human Resources Officer | 11. Februar 2026 A | 29.376 | 0 | 4 | $-2.987.366 |
| William T. Roberts | Chief Accounting Officer | 29. März 2023 M | 7.872 | 0 | 0 | $0 |
| Linda Shapiro Manning | Chief Medical Officer | 9. Februar 2022 A | — | 0 | 0 | $0 |
| Murray Stewart | Chief Medical Officer | 11. Februar 2021 A | — | 0 | 0 | $0 |
| Nithya Desikan | Chief Commercial Officer | 31. August 2020 M | 43.602 | 0 | 0 | $0 |
| Leonardus H.T. Van Der Ploeg | Chief Scientific Officer | 31. Mai 2019 M | 42.339 | 0 | 0 | $0 |
| Fred T. Fiedorek | Chief Medical Officer | 14. Februar 2018 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Direktor | 24. Juni 2026 A | 11.712 | 0 | 1 | $-3.711.840 |
| Stuart A Arbuckle | Direktor | 24. Juni 2026 A | 11.712 | 0 | 0 | $0 |
| Christophe Jean | Direktor | 24. Juni 2026 A | 11.712 | 0 | 0 | $0 |
| Jennifer L Good | Direktor | 24. Juni 2026 A | 11.712 | 0 | 0 | $0 |
| David W J Mcgirr | Direktor | 24. Juni 2026 A | 11.712 | 0 | 0 | $0 |
| Kimberly J Popovits | Direktor | 1. April 2026 A | — | 0 | 0 | $0 |
| Edward T. Mathers | Direktor | 12. März 2026 J | 14.168 | 0 | 0 | $0 |
| Camille L Bedrosian | Direktor | 24. Juni 2025 A | 7.000 | 0 | 0 | $0 |
| Todd Foley | Direktor | 15. März 2021 S | 909.258 | 0 | 0 | $0 |
| Neil Exter | Direktor | 6. Juni 2018 A | 0 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) L.P. | 10%-Eigentümer | 10. Oktober 2017 C | 545.256 | 0 | 0 | $0 |
| Ravi Viswanathan | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| Ipsen, S.A. | 10%-Eigentümer | 10. Oktober 2017 C | 833.099 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| Patrick J. Kerins | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| David M Mott | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| James M Barrett | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| Peter J Barris | 10%-Eigentümer | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
| Alastair Garfield | — | 13. August 2026 S | 2.295 | 0 | 4 | $-912.697 |
| Joseph Shulman | — | 13. August 2026 M | 15.915 | 0 | 8 | $-5.858.835 |
| Jennifer Chien | — | 13. August 2026 M | 0 | 0 | 1 | $-8.901.395 |
| Yann Mazabraud | — | 12. August 2026 M | 55.655 | 0 | 6 | $-6.620.591 |
| Simon Kelner | — | 11. Februar 2021 A | — | 0 | 0 | $0 |
| Scott D. Sandell | — | 10. Oktober 2017 C | 4.909.956 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| 30. April 2024 | — | Erste Einreichung | — | SEC | |
| Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd., C2 Life Sciences LLC, Perceptive Discovery Fund LP, Joseph Edelman ×3 Einreichungen | 17. April 2024 | — | Erste Einreichung | — | SEC |
| New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Forest Baskett, Patrick J. Kerins, Scott D. Sandell ×2 Einreichungen | 29. März 2023 | — | Erste Einreichung | Passive Anlage | SEC |
| MPM BioVentures V, L.P., MPM Asset Management Investors BV5 LLC, MPM BioVentures V GP LLC, MPM BioVentures V LLC, Ansbert Gadicke, Luke Evnin, Todd Foley ×2 Einreichungen | 26. Juni 2020 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 5. Februar 2020 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 12. Februar 2019 | — | Erste Einreichung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×5 Einreichungen | 10. August 2018 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 52 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 3,79% | 12.831 NS | 30. April 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,58% | 30.540 NS | 30. April 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,14% | 8.333 NS | 30. April 2026 | N-PORT |
| GURU · Global X Funds | 0,88% | 6.307 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,85% | 53.930 NS | 30. April 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0,68% | 1.538 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,57% | 487.129 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,54% | 3.734 SH | 8. August 2026 | Täglich |
| GSC · Goldman Sachs ETF Trust | 0,51% | 14.505 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,38% | 500.174 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,36% | 59.038 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,36% | 30.730 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,30% | 2.526 NS | 31. Mai 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,30% | 9.299 NS | 31. Mai 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,25% | 15.768 NS | 30. April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,24% | 2.335 NS | 30. April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 20.187 NS | 30. April 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 908.106 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,19% | 1.396.950 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 317.548 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,19% | 16.599 SH | 8. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,16% | 25.413 NS | 30. April 2026 | N-PORT |
| RSSL · Global X Funds | 0,13% | 22.978 NS | 30. April 2026 | N-PORT |
| SMLF · iShares Trust | 0,13% | 49.347 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,12% | 2.491 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 292.435 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,09% | 2.368 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.571.929 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,09% | 164.403 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 715.506 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 26.169 NS | 30. April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 4.339 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,07% | 1.948 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,07% | 17.482 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,06% | 7.134 NS | 31. Mai 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,06% | 10.436 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 3.421 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,05% | 1.974 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 12.161 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,02% | 49 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 16.766 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2.916 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.177.236 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4.502 SH | 8. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 12.173 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 83.947 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 14.047 SH | 8. August 2026 | Täglich |
| SCHK · SCHWAB STRATEGIC TRUST | 0,01% | 4.991 NS | 31. Mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 35.572 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 24 NS | 31. Mai 2026 | N-PORT |